Views & Analysis Deep Dive: R&D Disruption With costs skyrocketing and return on investment plummeting, R&D arguably needs disruption more than any other area of the industry.
R&D Deep Dive: R&D Innovation In this issue of Deep Dive we look at innovation in pharma R&D, asking how can pharmaceutical companies change up the development model with new strategies and technologies to cut waste
Views & Analysis CAR-Ts - a new weapon in the fight against cancer CAR-T - or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer.
Views & Analysis Pharma R&D is crying out for disruption – is AI the answer? Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
